Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): A multicentre, randomised, controlled phase 3 trial

Junichi Nishimura, Taroh Satoh, Mutsumi Fukunaga, Hiroyoshi Takemoto, Ken Nakata, Yoshihito Ide, Takayuki Fukuzaki, Toshihiro Kudo, Yasuhiro Miyake, Masayoshi Yasui, Shunji Morita, Daisuke Sakai, Mamoru Uemura, Taishi Hata, Ichiro Takemasa, Tsunekazu Mizushima, Yuko Ohno, Hirofumi Yamamoto, Mitsugu Sekimoto, Riichiro NezuYuichiro Doki, Masaki Mori

Research output: Contribution to journal › Article › peer-review

48 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): A multicentre, randomised, controlled phase 3 trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science